Mannitol is an osmotic diuretic agent useful in a variety of clinical conditions. This study is based on acid-base and electrolyte changes seen after the intravenous infusion of hypertonic mannitol for the prevention of cerebral edema. The study subjects were divided into 3 groups: for group A, an amount of 300-900 mL 15% mannitol was intravenously infused over the period of 60 to 90 minutes; for group B, 1,200-2,600 mL over 12 to 24 hours; and for group C, 3,200-4,900 mL over more than 24 hours. In group A, blood pH is increased from 7.43±0.07 to 7.46±0. 
Introduction
Metabolic alkalosis is a primary acid-base disturbance manifested as an elevated arterial pH and increased PaCO2 due to alveolar hypoventilation. A retrospective study of arterial blood gases in hospitalized patients showed that metabolic alkalemia was the most common acid-base disturbances, occurring in 51 % of the abnormal cases 1) . Metabolic alkalosis may . In both medical and surgical patients, alkalemia is most likely to occur in patients who are sicker and have had a complicated hospital course.
The mortality rate among medical patients exceeded that of surgical patients when the pH level was greater than 7.48. There was an inverse correlation between the pH value and the prognosis 3) .
Mannitol is a 6-carbon alcohol with a molecular weight of 182. For being an obligatory solute, mannitol may be used either as an osmotic diuretics to maintain water excretion, or to reduce the cerebral edema or intracranial pressure in cerebrovascular disease; a rapid infusion of 20% mannitol solution has been widely used 4) . Although various studies on the effectiveness of mannitol have been performed, there are few reports on acid-base disorder in Korea. This study is based on acid-base and electrolyte changes seen after the intravenous infusion of hypertonic mannitol was given for the prevention of cerebral edema. 
Study protocol
The study was a retrospective, open labeled controlled trial. Patients were randomly assigned to various amounts of 15% mannitol to be administered. Norwood, MA, USA).
Statistics
All data were expressed by mean±standard deviation. Comparisons of data were performed by using paired student t-test. p<0.05 is considered significant.
Results

Patients
There were 21 patients enrolled for the study and patients' profiles were described in Table 1 . There were 11 male and 10 female patients. Table 3) . The values showed significant difference before and after 15% mannitol infusion. Decreased creatinine level may be due to the change in the glomerular filtration rate. mg/dL, which may be due to increased glomerular filtration rate (Table 4) .
Discussion
Intravenous infusion of 15% mannitol may increase the blood pH and serum HCO3 -, and decrease the serum potassium and creatinine levels. Metabolic alkalosis may occur due to increased renal HCO3 -production after mannitol infusion 2) . Increased GFR after mannitol infusion may increase the distal tubular Na＋ loading and proximal tubular HCO3 -reabsorption. This phenomenon, in turn, may increase renal HCO3 -pro- In summary, these results showed that intravenous infusion of mannitol could induce metabolic alkalosis and hypokalemia, regardless of its dose. The mannitol induced alkalosis may be caused by increased renal HCO3 -production.
